Cited by 141Hormonal and reproductive studiesSperm and Testicular FunctionProstate Cancer Treatment and Research

Sex Steroid Hormone Concentrations and Risk of Death in US Men

Open access
Menke, Andy, Guallar, Eliseo, Rohrmann, Sabine, Nelson, William G., Rifai, Nader, Kanarek, Norma, Feinleib, Manning, Michos, Erin D. +2 more·2010·American Journal of Epidemiology

Abstract

The association of sex hormone levels with mortality over a median of 16 years of follow-up was evaluated in a prospective cohort study. The study included 1,114 US men who participated in phase 1 (1988-1991) of the Third National Health and Nutrition Examination Survey Mortality Study and had no history of cardiovascular disease or cancer at baseline. Multivariable adjusted hazard ratios for all-cause mortality associated with a decrease in hormone concentration equal to the difference between the 90th and 10th percentiles of the sex hormone distributions were estimated by using proportional hazards regression. The hazard ratios associated with low free testosterone and low bioavailable testosterone levels were 1.43 (95% confidence interval (CI): 1.09, 1.87) and 1.52 (95% CI: 1.15, 2.02), respectively, for follow-up between baseline and year 9; they were 0.94 (95% CI: 0.51, 1.72) and 0.98 (95% CI: 0.56, 1.72), respectively, for follow-up between year 9 and year 18. Men with low free and bioavailable testosterone levels may have a higher risk of mortality within 9 years of hormone measurement. Future studies should be conducted to fully characterize the association of low free and bioavailable testosterone concentrations and mortality in men and to describe the mechanism underlying the association.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kwp415

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Men with low levels of free testosterone and bioavailable testosterone are at a higher risk of mortality.

    “some studies have also demonstrated that men with low levels of free testosterone and bioavailable testosterone are at a higher risk of mortality, 8-10”

    From Cigarette smoking has a positive and independent effect on testosterone levels (2013) · cites this paper as [8]

    The Discussion reports that low free and bioavailable testosterone were associated with higher mortality in adult US men during the first nine years after measurement. The citing sentence omits that time limit: the association did not persist during follow-up from years 9 to 18. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007; 30(2):234-238.
  2. Araujo AB, Kupelian V, Page ST, et al. Sex steroids and all- cause and cause-specific mortality in men. Arch Intern Med. 2007;167(12):1252-1260.
  3. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93(1):68-75.
  4. Lehtonen A, Huupponen R, Tuomilehto J, et al. Serum testosterone but not leptin predicts mortality in elderly men. Age Ageing. 2008;37(4):461-464.
  5. Shores MM, Matsumoto AM, Sloan KL, et al. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166(15):1660-1665.
  6. Smith GD, Ben-Shlomo Y, Beswick A, et al. Cortisol, testos- terone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005;112(3):332-340.
  7. Nierman DM, Mechanick JI. Hypotestosteronemia in chronically critically ill men. Crit Care Med. 1999;27(11): 2418-2421.
  8. Dong Q, Hawker F, McWilliam D, et al. Circulating immu- noreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol (Oxf). 1992;36(4):399-404.
  9. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation. 1988;78(3):539-545.
  10. Haffner SM, Moss SE, Klein BE, et al. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1996;19(10):1045- 1050.
  11. Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med. 2007;167(20):2249-2254.
  12. Eaton NE, Reeves GK, Appleby PN, et al. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer. 1999;80(7):930-934.
  13. Hak AE, Witteman JC, de Jong FH, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab. 2002;87(8):3632-3639.
  14. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992;2(5): 675-682.
  15. Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a sys- tematic review and meta-analysis. JAMA. 2006;295(11): 1288-1299.
  16. Kahn SM, Hryb DJ, Nakhla AM, et al. Sex hormone-binding globulin is synthesized in target cells. J Endocrinol. 2002; 175(1):113-120.
  17. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocri- nol Metab. 2006;91(6):1995-2010.

Cited by

Sorted by citations

Authors
Menke, A., Guallar, E., Rohrmann, S., Nelson, W. G., Rifai, N., Kanarek, N., Feinleib, M., Michos, E. D., Dobs, A., & Platz, E. A.
Affiliations
  • Johns Hopkins University (US)
  • Harvard University (US)
Corresponding author
Platz, Elizabeth A.
Venue
American Journal of Epidemiology
Published
2010-01-18
Volume
171
Issue
5
Pages
583-592
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2125314787
Cited by
141
References
4
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 18 · 2013: 13 · 2012: 10
FWCI
9.27
Type
journal article
Language
en
Open access
Locations
  • American Journal of Epidemiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Johns Hopkins University
  • NIH
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
sex hormones, testosterone, free testosterone, bioavailable testosterone, all-cause mortality, men, hormone levels, mortality risk
MeSH terms
Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Forecasting, Humans, Male, Middle Aged, Mortality, Neoplasms, Gonadal Steroid Hormones, United States, Risk Assessment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review